.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
US Army
Boehringer Ingelheim
McKinsey
Fish and Richardson
QuintilesIMS
Dow
Express Scripts
Covington
Moodys

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075047

« Back to Dashboard

NDA 075047 describes ACEBUTOLOL HYDROCHLORIDE, which is a drug marketed by Amneal Pharm, Mylan, and Watson Labs, and is included in three NDAs. It is available from seven suppliers. Additional details are available on the ACEBUTOLOL HYDROCHLORIDE profile page.

The generic ingredient in ACEBUTOLOL HYDROCHLORIDE is acebutolol hydrochloride. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acebutolol hydrochloride profile page.

Summary for 075047

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 075047

Mechanism of ActionAdrenergic beta-Antagonists

Suppliers and Packaging for NDA: 075047

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACEBUTOLOL HYDROCHLORIDE acebutolol hydrochloride CAPSULE;ORAL 075047 ANDA Major Pharmaceuticals 0904-6173 0904-6173-60 100 CAPSULE in 1 BOTTLE (0904-6173-60)
ACEBUTOLOL HYDROCHLORIDE acebutolol hydrochloride CAPSULE;ORAL 075047 ANDA AvKARE, Inc. 42291-101 42291-101-90 90 CAPSULE in 1 BOTTLE (42291-101-90)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 200MG BASE
Approval Date:Dec 30, 1999TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 400MG BASE
Approval Date:Dec 30, 1999TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
Teva
Cantor Fitzgerald
Citi
Daiichi Sankyo
Accenture
Cerilliant
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot